authors
- Sonpavde, Guru
- Sternberg, Cora N
- Lee, Jae-Lyun
- de Miranda, Paulo Andre Palhares
- Lima, Ana Rita
- Sarkeshik, Makan
- Hotte, Sebastien
An open-label, multicenter, phase IIIb study of patients with urinary tract carcinoma (UTC) (STRONG): Interim safety results for fixed-dose durvalumab (D) monotherapy (module A)
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- February 20, 2020
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal